ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
CSL LIMITED
167.100
-2.400
-1.42%
成交量：
80.66萬
成交額：
1.35億
市值：
800.26億
市盈率：
-22.40
高：
169.360
開：
167.000
低：
165.790
收：
169.500
52周最高：
216.751
52周最低：
88.837
股本：
4.79億
流通股本：
4.79億
量比：
0.79
換手率：
0.17%
股息：
4.07
股息率：
2.44%
每股收益(TTM):
-7.460
每股收益(LYR):
-7.460
淨資產收益率：
-15.83%
總資產收益率：
7.26%
市淨率：
3.88
市盈率(LYR):
-22.40
資料載入中...
總覽
公司
新聞
公告
英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者
路透中文
·
09/01
CSL重大擴產計劃：大幅提升免疫球蛋白及白蛋白生產能力，惠及罕見病與重症患者
美股速递
·
09/01
CSL達成協議：為美國藥品定價及特定232條款關税風險增添確定性
美股速递
·
09/01
CSL有限公司：項目預計創造至少300個製藥製造業新崗位及約800個建築及相關崗位
美股速递
·
09/01
CSL與美國政府達成協議 降價藥品並助力本土製造投資
美股速递
·
09/01
CSL有限公司：新協議助力降低療法價格，彰顯15億美元擴建伊利諾伊州美國產能計劃
美股速递
·
09/01
特朗普政府將宣佈藥品定價協議
路透中文
·
09/01
CSL Limited擬斥資約15億美元擴大美國血漿生產版圖
美股速递
·
08/18
數據簡報-全球製藥企業斥資數十億以擴大在美業務
路透中文
·
08/11
數據簡報-全球製藥企業斥資數十億以擴大在美國的市場份額
路透中文
·
08/10
CSL有限公司：歐盟委員會決定撤銷Tavneos在歐盟及歐洲經濟區國家的上市許可
美股速递
·
08/06
異動解讀 | CSL Limited盤中大漲5%，宣佈啓動下一代免疫球蛋白臨床試驗
异动解读
·
07/29
CSL有限公司將開展臨床試驗，驗證下一代Horizon 2工藝生產的免疫球蛋白有效性與安全性
美股速递
·
07/29
安登布里（Andembry）展現良好安全性；多數患者在12個月治療期內未出現發作
美股速递
·
07/27
CSL公布Andembry®治療兒童遺傳性血管性水腫IIIb期積極結果，支持擴大兒科適應症申報
美股速递
·
07/27
歐盟就賽諾菲針對競爭對手流感疫苗可能存在的反競爭行為徵集反饋意見
美股速递
·
07/08
賽諾菲回應歐盟調查：堅信自身行為始終完全符合所有適用法律法規
美股速递
·
06/26
賽諾菲就歐盟調查發表聲明：在整個過程中與歐盟委員會保持全面合作
美股速递
·
06/26
分析-2025年，隨着高價基因療法上市數量減少，美國新藥價格出現下降
路透中文
·
06/25
得克薩斯州訓練中心爆發疫情後，美軍要求部分人員接種流感疫苗
路透中文
·
06/25
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/CSL.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":167.1,"timestamp":1789107120000,"preClose":169.5,"halted":0,"volume":806570,"delay":0,"changeRate":-0.014159292035398263,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.459564974902398,"marketStatus":"休市中","change":-2.4,"latestTime":"09-11 16:12:00 AEST","open":167,"high":169.36,"low":165.79,"amount":134554029,"amplitude":0.021062,"askPrice":167.17,"askSize":148,"bidPrice":166.8,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-7.459564974902398,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":169.5,"dividendRate":0.024385,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0.7945711806017333,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":169.5,"auctionPrice":167.07,"auctionVolume":285295,"auction":3,"marketStatus":"盘后竞价","timestamp":1789107002475}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.459565,"volumeRatio":0.7945711806017333,"shares":478911979,"dividePrice":4.071389,"high":169.36,"amplitude":0.021062,"preClose":169.5,"low":165.79,"week52Low":88.837,"pbRate":"3.88","psRate":"3.63","week52High":216.751,"institutionHeld":0,"latestPrice":167.1,"committee":-0.922078,"eps":-7.459564974902398,"divideRate":0.024365,"volume":806570,"delay":0,"ttmEps":-7.459564974902398,"open":167,"prevYearClose":168.21,"prevWeekClose":172.243,"prevMonthClose":169.351,"prevQuarterClose":113.256,"fiveDayClose":172.243,"twentyDayClose":134.734,"sixtyDayClose":114.815,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BIB","CSL.AU","LU2468319806.SGD","AMGN","BK4588","IBBQ","LU0320765992.SGD","LU2112291526.USD","LU1061106388.HKD","LU2242652126.USD","BK4585","IE0002141913.USD","BK7511","BK4139","BK7501","LU2242646821.SGD","PJP","BK4566","IE0009355771.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2089984988.USD","BK4599","LU0122379950.USD","IBB","LU0868494617.USD","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU1571399168.USD","BK4533","BK7067","LU1983299246.USD","BK4534","BK7508","IE00B4R5TH58.HKD","TBXU","BK4581","PBE","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160995524","title":"CSL重大擴產計劃：大幅提升免疫球蛋白及白蛋白生產能力，惠及罕見病與重症患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1160995524","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160995524?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:27","pubTimestamp":1788204431,"startTime":"0","endTime":"0","summary":"CSL宣布了一项重大扩建项目，此举将显著增强其为罕见疾病及严重病症患者生产免疫球蛋白和白蛋白的能力。这一战略性举措不仅标志着公司在生物制药领域迈出的坚实一步，更意味着全球更多患者有望获得这些关键性治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181327820","title":"CSL達成協議：為美國藥品定價及特定232條款關税風險增添確定性","url":"https://stock-news.laohu8.com/highlight/detail?id=1181327820","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181327820?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:25","pubTimestamp":1788204309,"startTime":"0","endTime":"0","summary":"CSL宣布，已通过相关协议为其在美国药品定价及部分第232条款关税方面的潜在风险敞口提供了更多确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","CSL.AU","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194972911","title":"CSL有限公司：項目預計創造至少300個製藥製造業新崗位及約800個建築及相關崗位","url":"https://stock-news.laohu8.com/highlight/detail?id=1194972911","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194972911?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:24","pubTimestamp":1788204248,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布，其新项目将带来显著的就业增长。据估计，该项目将直接催生至少300个制药制造领域的全新工作岗位。与此同时，建筑业及相关配套行业也将迎来约800个就业机会。这一系列的岗位创造计划，无疑将为当地经济注入新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100124360","title":"CSL與美國政府達成協議 降價藥品並助力本土製造投資","url":"https://stock-news.laohu8.com/highlight/detail?id=1100124360","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100124360?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:23","pubTimestamp":1788204189,"startTime":"0","endTime":"0","summary":"生物技术巨头CSL已与美国政府签署新协议，旨在降低部分药品价格，同时加大对美国本土生产设施的投资力度。此举被视为制药行业响应政府控价压力、巩固供应链安全的最新动向之一。根据协议内容，该公司将在积极推进制造业扩张的同时，向市场提供更具竞争力的定价。业界分析指出，这一安排既反映了企业在政策环境下的策略调整，也凸显了医疗健康领域对成本控制与产能韧性的双重诉求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","CSL.AU","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171032857","title":"CSL有限公司：新協議助力降低療法價格，彰顯15億美元擴建伊利諾伊州美國產能計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1171032857","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171032857?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:23","pubTimestamp":1788204189,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布，一系列新达成的协议将支持其疗法产品价格的进一步下调，并充分体现了该公司斥资15亿美元用于扩建其位于伊利诺伊州的美国生产基地的宏伟蓝图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7508","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普 预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","LU1066053197.SGD","BK4585","ELIS","LU0114720955.EUR","CSL.AU","LU0466842654.USD","LU0868494617.USD","LU1145028129.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU2112291526.USD","IE00B1BXHZ80.USD","BK4139","LU2750360997.AUD","PJP","SG9999014880.SGD","TBXU","JDOC","LU0320765059.SGD","LU0289739699.SGD","LU2896262040.SGD","LU0323591593.USD","ELIL","LU0225283273.USD","LU0417517546.SGD","LLYX","LU0174119429.USD","IE00BK4W5L77.USD","TRUH","WDNA","LLY","LLYZ","LU0354030511.USD","LU1267930730.SGD","BK4568","SG9999003800.SGD","LU2089984988.USD","LU0097036916.USD","IE00BKDWB100.SGD","LU0306807586.USD","BK4588","LU2168564149.EUR","LU2265009873.SGD","LU2357305700.SGD","LU2237438978.USD","LU2361045086.USD","LU2552382215.SGD","MEDX","SG9999014906.USD","SG9999018857.SGD","LU1804176565.USD","CURE","LU0672654240.SGD","LU1868836591.USD","IE0004445239.USD","VHT","LU1814569148.SGD","SGXZ99366536.SGD","IYH","LU0109391861.USD","LU2168564222.USD","LU2271345857.HKD","LU2324357040.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","BK7511","LU2461242641.AUD","LU2471134796.USD","PFE","SG9999001176.USD","LU0170899867.USD","SG9999002224.SGD","LU0256863811.USD","LU0354030438.USD","LU2360106947.USD","LU0820561909.HKD","LU2361044865.SGD","LU1883839398.USD","LU0106261372.USD","LU0353189680.USD","LU0432979614.USD","LU2471134952.CNY","SG9999001176.SGD","LU2063271972.USD","IE00B4R5TH58.HKD","LU2023251221.USD","LU2552382058.USD","LU0266013472.USD","LU1894683348.USD","LU0096364046.USD","LU0320765992.SGD","LU0820561818.USD","LU1720051017.SGD","LU1868836757.USD","LU1057294990.SGD","CANC","LU0964807845.USD","BK4599","IBB","FTXH","LU0345770308.USD","LU0122379950.USD","LU0203202063.USD","LU1712237335.SGD","LU1979441026.SGD","LU2211815571.USD","LU0203201768.USD","LU0882574055.USD","PPH","BK4592","LU0345770993.USD","LU1868837300.USD","SG9999018865.SGD","SG9999015978.USD","LU2168564495.EUR","GB00BDT5M118.USD","IE00BN29S564.USD","LU0943347566.SGD","BK4566","LU0820562030.AUD","BK4007","LU0316494557.USD","BK7508","LU0640476718.USD","LU1629891620.HKD","LU1989771016.USD","LU2491050154.USD","BIB","LU2552382132.HKD","LU2746668461.USD","LU0471298777.SGD","SG9999015986.USD","LU2417539215.USD","SG9999002232.USD","LU0256863902.USD","LU2468319806.SGD","LU0079474960.USD","LU2471134879.HKD","AGNG","AMGN","LU0708995401.HKD","LU0823416689.USD","IE00B19Z3B42.SGD","IE00B7KXQ091.USD","LU0471298694.HKD","LU0061475181.USD","LU0306806265.USD","OZEM","IXJ","LU2237443895.HKD","SGXZ31699556.SGD","LU1093756325.SGD","LU2456880835.USD","RXL","IE00B1XK9C88.USD","LU1548497426.USD","LU2242652126.USD","IE00B19Z3581.USD","SG9999017495.SGD","LU2023250504.SGD","LU2756315664.SGD","LU0385154629.USD","LU0689472784.USD","LU2756315318.SGD","SGXZ51526630.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","IE00B3T34201.USD","LU1720051108.HKD","LU0094547139.USD","LU0238689110.USD","LU1571399168.USD","LU1323610961.USD","BK4581","LU1894683264.USD","LU1691799644.USD","LU0889565916.HKD","IHE","LU2089284900.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1366192091.USD","LU2237443978.SGD","SG9999014914.USD","04332","LU2491050071.SGD","SG9999015945.SGD","IE0002141913.USD","IE0009355771.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU2237443622.USD","LU1232071149.USD","LU1623119135.USD","PBE","BK4534","LU1551013425.SGD","SG9999011175.SGD","LU1069344957.HKD","BK4533","LU1917777945.USD","LU1983299246.USD","LU2462157665.USD","LU1280957306.USD","LU2602419157.SGD","TMED","LU2213496289.HKD","LU2111349929.HKD","LU0353189763.USD","IE00BJJMRX11.SGD","LU0787776722.HKD","LU0321505439.SGD","ILDR","SG9999015952.SGD","HRTS","SGXZ81514606.USD","FHLC","LLII","LU2168563687.JPY","LU0786609619.USD","XLV","IE00BK4W5M84.HKD","LU1551013342.USD","LU0133085943.USD","LU0683600562.USD","IONS","LU0456855351.SGD","LU2264538146.SGD","LU2087625088.SGD","LU2596442595.SGD","LU0823434740.USD","SG9999001440.SGD","IE00BFSS8Q28.SGD","LU2028103732.USD","IE0004445015.USD","LU0158827948.USD","LU0823434583.USD","IE00BJT1NW94.SGD","LU1988902786.USD","LU1868837136.USD","LU2236285917.USD","BK7501","LU0225284248.USD","IE00BFSS7M15.SGD","BK4550","GDOC","IBBQ","LU2108987350.USD","LU0985481810.HKD","BK4516","IE00BKPKM429.USD","LU0210536198.USD","LU0006306889.USD","LU2023250330.USD","LU2106854487.HKD","LU2237443465.HKD","LU2491049909.HKD","IE00BWXC8680.SGD","LU1093756168.USD","LU0198837287.USD","IE00B775H168.HKD","LU0158827781.USD","IE00BJLML261.HKD","IE00B4JS1V06.HKD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1035775433.USD","IE000M9KFDE8.USD","LU2168564065.EUR","LU1291159041.SGD","LU2471134523.USD","LU0882574139.USD","LU2462591350.SGD","LU2237443382.USD","LU0234572021.USD","LU2361044949.HKD","LU2750360641.GBP","LU1066051498.USD","LU1023059063.AUD","THNR","LU0109394709.USD","LU1974910355.USD","LU2237443549.SGD","IE00B2B36J28.USD","LU1868836914.USD","MHIP","BBH","MEDI","LU2242646821.SGD","BK7067","LU2089283258.USD","IE00BBT3K403.USD","LU0321505868.SGD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198570797","title":"CSL Limited擬斥資約15億美元擴大美國血漿生產版圖","url":"https://stock-news.laohu8.com/highlight/detail?id=1198570797","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198570797?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 06:02","pubTimestamp":1787004131,"startTime":"0","endTime":"0","summary":"CSL Limited宣布，计划投入约15亿美元，以进一步拓展其在美国的血浆制造业务布局。这一重大投资决策，彰显了该公司在全球血浆市场持续深耕的战略意图。据悉，这笔资金将用于扩大生产设施、提升产能，并强化其在美国本土的供应链体系。此举不仅有望巩固CSL在行业内的领先地位，更可能对全球血浆制品的供应格局产生深远影响。随着项目的逐步推进，CSL的产能优势或将进一步转化为市场竞争中的核心驱动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7508","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658591102","title":"數據簡報-全球製藥企業斥資數十億以擴大在美業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2658591102","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658591102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:59","pubTimestamp":1786463961,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美业务更新了第18段中关于百健生产工厂的数据路透8月11日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。这家制药公司宣布将投资 6.5 亿美元 ，以扩大其位于波多黎各洪科斯工厂的药品生产规模，此举预计将创造近 750 个就业岗位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S448167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","IE000F7OJYX1.SGD","ELIL","LU0211331839.USD","LU1069344957.HKD","LU2471134952.CNY","LU1267930813.SGD","BMED","LU1093756168.USD","LU2125909247.SGD","SGXZ51526630.SGD","LU2168564222.USD","LU2357305700.SGD","IE0034235303.USD","LU1674673691.USD","LU0820561818.USD","LU1037948541.HKD","IE0000B7K699.USD","LU2089984988.USD","LU0006306889.USD","IE00B894F039.SGD","LU1228905037.USD","LU0210528500.USD","LU2487616109.SGD","LU1814569148.SGD","LU0965509010.AUD","LU1983299246.USD","MEDI","IE00BKVL7J92.USD","LU2461242641.AUD","LU2462157665.USD","LU0289739343.SGD","LU2063271972.USD","GILD","LU0289961442.SGD","LU2168564495.EUR","LU2361044865.SGD","LU0070217475.USD","IE00B3T34201.USD","LU0985481810.HKD","LU2456880835.USD","LU1043141123.HKD","IE00B1BXHZ80.USD","LU0097036916.USD","LU0353189680.USD","LU1069347547.HKD","IE0002270589.USD","LU1116320737.USD","IE00B19Z9Z06.USD","LU1868836591.USD","LU1923622614.USD","LU0912757837.SGD","SG9999002232.USD","LU0128525929.USD","LU0174119429.USD","LU1670711123.USD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","LU1934455194.USD","IE00BLSP4239.USD","SG9999015978.USD","LU2129689431.USD","IE00BJT1NW94.SGD","LU1699723380.USD","LU0094547139.USD","LU1043141396.HKD","LU0640476718.USD","LU1979441026.SGD","LU0198837287.USD","LU1934455863.HKD","LU2087625088.SGD","LU0942090050.USD","IE00B7KXQ091.USD","LU1670628061.USD","BK4583","IE00BJLML261.HKD","LLYX","LU2357627491.SGD","LU0158827781.USD","FHLC","IE00BDGV0183.EUR","PBE","LU0353189763.USD","MEDX","PFE","LU1064131342.USD","LU1868836757.USD","IE00B42XCP33.USD","LU2023250330.USD","SG9999001176.SGD","LU1868836914.USD","LU1323610961.USD","IE0004445015.USD","LU0472753341.HKD","LU2417539215.USD","LU0208291251.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","IE00BFXG1179.USD","BK4533","LU1430594728.SGD","LU2552382132.HKD","LU2168564149.EUR","LU2237438978.USD","LU1670711040.USD","LU2746668461.USD","LU1894683348.USD","LU2750360641.GBP","LU0553294199.USD","IE00B19Z3581.USD","LU1035775433.USD","THNR","ELIS","BK4599","IE000MB6IJN5.SGD","LU1196500208.SGD","LU1244550494.USD","LU0256863902.USD","LU0385154629.USD","LU1941712348.USD","LU0820562030.AUD","LU0345769128.USD","XLV","LU2237443622.USD","LU1035773651.USD","SGXZ99366536.SGD","LU1670710588.SGD","LU1988902786.USD","LU1974910355.USD","BK4578","LU2491049909.HKD","IE00BN8TJ469.HKD","LU2242652126.USD","LU2236285917.USD","LU0109391861.USD","IE00B4JS1V06.HKD","LU0354030438.USD","SG9999014575.USD","IE00B2B36J28.USD","LU2756315664.SGD","LU0069063385.USD","LU1201861249.SGD","LU0787776722.HKD","IE0002141913.USD","LU0395794307.EUR","TMED","CSL.AU","BK4516","IHE","IE0001KFT4U8.USD","LU1778281490.HKD","LU0057025933.USD","IE00BWXC8680.SGD","LU1496350171.SGD","LU1868837136.USD","GB00BDT5M118.USD","HRTS","LU1629891620.HKD","LU1883839398.USD","LU2360032135.SGD","LU0882574139.USD","LU1267930730.SGD","LU2896262040.SGD","LU0320765059.SGD","LU0795875169.SGD","LU0267386448.USD","LU1718418525.SGD","LU0354030511.USD","LU2023250843.SGD","TRUH","LU0994945656.USD","SG9999014914.USD","LU2264538146.SGD","LU1914381329.SGD","LU0345770308.USD","LU2361044949.HKD","WDNA","LU0683600562.USD","LU0965509101.SGD","LU0210536198.USD","SG9999015358.SGD","LU0203345920.USD","LU0211327993.USD","LU1548497426.USD","LU1989771016.USD","LU2471134523.USD","BK4581","LU1720051108.HKD","MHIP","LU0225771236.USD","LU0203202063.USD","LU2108987350.USD","BK4592","LU0432979614.USD","LU0820561909.HKD","BK4585","LU2028103732.USD","LU0795875086.SGD","AZN","SG9999002224.SGD","LU1093756325.SGD","LU2087621335.USD","LU0109394709.USD","LU0130517989.USD","LU1221951129.SGD","ILDR","LU1670710661.SGD","LU1261432733.SGD","LU0823416689.USD","LU2430703095.HKD","SG9999001440.SGD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU1023059063.AUD","LU0234570918.USD","LU2237443978.SGD","LU2750360997.AUD","LU1585245621.USD","LU1868837300.USD","LU0170899867.USD","LU0320765992.SGD","LU0672654240.SGD","SG9999014567.USD","LU1267930573.SGD","LU0203347892.USD","PPH","LU2129689605.HKD","IE00B19Z3B42.SGD","LLII","IE00BFTCPJ56.SGD","LU2552382215.SGD","LU0980610538.SGD","IE00B19Z9P08.USD","GDOC","LU1066051811.HKD","LU0949170772.SGD","LU1366192091.USD","LU2360106947.USD","SG9999014542.SGD","LU0124676726.USD","LU1712237335.SGD","SG9999015986.USD","LU0320765646.SGD","LU2023251221.USD","LU2125154778.USD","IE00BKDWB100.SGD","BIIB","BK4559","LU2491050071.SGD","SG9999014559.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU2491050154.USD","BK4534","LU0471298694.HKD","LU1059921491.USD","LU0310799852.SGD","LU0965508806.USD","LU1057294990.SGD","LU0321505868.SGD","LU2089284900.SGD","IE00BFSS7M15.SGD","LU2237443382.USD","LU2430703178.SGD","IE00BBT3K403.USD","LU0545562505.USD","ABBV","LU0708995401.HKD","LU2242646821.SGD","LU2471134879.HKD","LU1935042991.SGD","LU0029864427.USD","IE00BVYPNW00.USD","IE00BJJMRX11.SGD","BK7511","IE0004445239.USD","IE00B775H168.HKD","JNJ","LU0158827948.USD","LU0053666078.USD","LU1506573853.SGD","LU2756315318.SGD","LU1267930490.SGD","AGNG","SG9999018857.SGD","BK4504","LU1032466523.USD","LU1929549753.HKD","LU2125154935.USD","LU0266013472.USD","LU0786609619.USD","SG9999001176.USD","LU1941712264.USD","IE0009355771.USD","LU0985320562.USD","LU0316494557.USD","LU2211815571.USD","LU2433249047.HKD","BK7067","RXL","LU0466842654.USD","LU2430703251.USD","IE00BGHQF631.EUR","LU1989772840.SGD","LU1720051017.SGD","LU2213496289.HKD","SG9999014880.SGD","BK4550","BK4566","IE00B1XK9C88.USD","LU1674673428.USD","LU1232071149.USD","LU1291159041.SGD","04332","SGXZ81514606.USD","LU0861579265.USD","LU1221951046.USD","LU2347655156.SGD","LU0306807586.USD","IBBQ","GLAM","LU1934455277.USD","LU1244550221.USD","LU0345769631.USD","BK4568","SG9999015952.SGD","LU2111349929.HKD","LU1061106388.HKD","LU0708994859.HKD","OZEM","LU0162691827.USD","SGXZ57979304.SGD","LU2237443549.SGD","LU0098860793.USD","LU2271345857.HKD","LU2112291526.USD","CANC","LU0689472784.USD","LU0943347566.SGD","SG9999013999.USD","LU2361045086.USD","LU0792757196.USD","LU1145028129.USD","LU2347655073.USD","SGXZ31699556.SGD","LU0320765489.SGD","IYH","MRK","LU1066051498.USD","LU0070302665.USD","LU0868494617.USD","SG9999014906.USD","LU2324357040.USD","LU0072461881.USD","LU0889565916.HKD","LU0289739699.SGD","LU1551013425.SGD","IE00BZ1G4Q59.USD","LU0237698245.USD","LU1829250122.USD","SG9999017495.SGD","LU1670627923.USD","IE00BK4W5M84.HKD","LU0211328371.USD","LU0130102774.USD","LU2505996681.GBP","IE000M9KFDE8.USD","LU2237443465.HKD","IE00BJJMRY28.SGD","LU0964807845.USD","FTXH","LU2746668974.SGD","LU2471134796.USD","LU1162221912.USD","LU1127390331.HKD","AZNH","BK7501","SG9999015945.SGD","LU0133085943.USD","LU1074936037.SGD","LU1989772923.USD","BMY","LU2592432038.USD","LU0058720904.USD","LU2125909593.SGD","LU0306806265.USD","LU0345770993.USD","LU1732799900.SGD","LU1839511570.USD","LU0106261372.USD","LU2133065610.SGD","LU0882574055.USD","LU2023250504.SGD","LU2168564065.EUR","LU0477156953.USD","IE00BLSP4452.SGD","LU2106854487.HKD","LU0096364046.USD","LU2265009873.SGD","IE0005OL40V9.USD","LU1917777945.USD","IE00BN29S564.USD","LU0417517546.SGD","IE00BVYPNV92.GBP","LU0689626769.HKD","CURE","JDOC","LU0545039389.USD","LU0079474960.USD","LU1121112475.USD","LU1003077747.HKD","LU2237443895.HKD","SGXZ80539844.SGD","LU1066051225.USD","AMGN","LU0265550946.USD","IBB","BK4588","LU2552382058.USD","LU0310800379.SGD","LU0889566641.SGD","LU0471298777.SGD","IE000WAW04H5.SGD","LLYZ","PAWZ","IE00B4R5TH58.HKD","LU0225284248.USD","LU0965509283.SGD","LU1116320901.HKD","PJP","LU0823434740.USD","IE000SO60NU8.SGD","LU1496350502.SGD","LLY","IE00BSNM7G36.USD","LU0456855351.SGD","LU0203201768.USD","LU1732800096.USD","LU1551013342.USD","LU1032955483.USD","LU1066053197.SGD","LU0323591593.USD","VHT","SG9999015341.SGD","LU0321505439.SGD","LU1244550577.SGD","SG9999018865.SGD","LU0868494708.USD","LU2403377893.USD","BK4532","LU2089283258.USD","LU1894683264.USD","BK7508","LU0238689110.USD","IE00BFSS8Q28.SGD","LU0426417589.USD","BK4139","LU1623119135.USD","LU2129689514.USD","LU2505996509.AUD","LU0823434583.USD","SG9999003800.SGD","SG9999011175.SGD","LU0859254822.USD","LU2168563687.JPY","LU2468319806.SGD","LU0511384066.AUD","LU1280957306.USD","LU0661504455.SGD","LU0234572021.USD","LU0256863811.USD","IE00B3PB1722.GBP","LU0738911758.USD","LU1228905540.USD","LU0225283273.USD","LU0726765562.USD","SG9999014898.SGD","LU0265550359.USD","LU1804176565.USD","BBH","BIB","LU0426412945.USD","LU1571399168.USD","LU2596442595.SGD","LU2602419157.SGD","TBXU","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931998","title":"數據簡報-全球製藥企業斥資數十億以擴大在美國的市場份額","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931998","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931998?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 21:18","pubTimestamp":1786367928,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美国的市场份额修改发稿日期，补充百时美施贵宝的投资计划路透8月10日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。赛诺菲计划通过直接投资公司现有基地以及与其他国内制造商建立合作伙伴关系，扩大其在美国的生产能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4470YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","LU2756315318.SGD","LU1506573853.SGD","LU2168563687.JPY","IE0002270589.USD","LU1989771016.USD","LU0158827781.USD","LU1267930813.SGD","LU2168564065.EUR","LU1093756325.SGD","LU0170899867.USD","LU2462591350.SGD","BK7511","LU2471134523.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","04332","LU0098860793.USD","LU1023059063.AUD","LU1043141123.HKD","IE00BWXC8680.SGD","LU1732800096.USD","LU0070217475.USD","LU2471134796.USD","LU0097036916.USD","CURE","LU1069347547.HKD","LU0964807845.USD","LU0130102774.USD","LU1934455863.HKD","LU1066051811.HKD","LU2242652126.USD","LU1228905037.USD","LU1201861249.SGD","IE00B19Z3581.USD","LU0289961442.SGD","LU0070302665.USD","LU0985481810.HKD","LU2089283258.USD","LU0208291251.USD","LU2360106947.USD","LU1585245621.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU0868494617.USD","LU2357627491.SGD","LU0965508806.USD","LU1221951046.USD","SGXZ31699556.SGD","LU1037948897.HKD","LU1430594728.SGD","LU1974910355.USD","LU1323610961.USD","LU0994945656.USD","LU2433249047.HKD","BK4559","LU2265009873.SGD","LU2596442595.SGD","LU0058720904.USD","BK7067","LU0211327993.USD","IE000WAW04H5.SGD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","BK4504","SG9999015986.USD","LU0130517989.USD","LU2347655156.SGD","LU0154236417.USD","LU2361044949.HKD","LU2236285917.USD","LU0237698245.USD","VHT","LU0069063385.USD","LU0985320562.USD","LU0861579265.USD","LU1914381329.SGD","SG9999001440.SGD","LU2461242641.AUD","LU2552382215.SGD","IE00B775H168.HKD","LU2750360997.AUD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2111349929.HKD","LU2125909247.SGD","LU0823416689.USD","BIB","SGXZ99366536.SGD","LU0859254822.USD","IE00B1XK9C88.USD","LU1670710588.SGD","LU0353189763.USD","LU0122379950.USD","LU2129689431.USD","LU1244550221.USD","IE000MB6IJN5.SGD","LU1868837136.USD","LU2237443465.HKD","LU1718418525.SGD","LU1280957306.USD","LU0689472784.USD","LU0096364046.USD","IE00B894F039.SGD","LU2491049909.HKD","LU1261432733.SGD","LU0211331839.USD","LU0456855351.SGD","LU0792757196.USD","LU0354030438.USD","LU1037948541.HKD","IE0004445015.USD","LU0265550946.USD","LU0787776722.HKD","LU2746668461.USD","LU1923622614.USD","LU1732799900.SGD","LU1839511570.USD","LU0466842654.USD","LU1629891620.HKD","LU2213496289.HKD","LU1941712264.USD","IE0001KFT4U8.USD","SG9999018857.SGD","LU0965509101.SGD","SG9999014898.SGD","LU0965509010.AUD","RXL","SG9999001176.SGD","SGXZ81514606.USD","LU0053666078.USD","AGNG","GDOC","LU2168564222.USD","GSK","LU0553294199.USD","LU1066051225.USD","LU0426417589.USD","LU0114720955.EUR","LU0511384066.AUD","LU2750360641.GBP","LU0708995401.HKD","LU0868494708.USD","LU2347655073.USD","LU1228905540.USD","LU2487616109.SGD","LU0234572021.USD","LU1814569148.SGD","LU1983299246.USD","IHE","LU0823434583.USD","LU2403377893.USD","LU1162221912.USD","LU2237438978.USD","LU2237443978.SGD","LU2271345857.HKD","LU1988902786.USD","LU0942090050.USD","LU2129689605.HKD","LU0109394709.USD","LU1116320737.USD","LU2746668974.SGD","IE00BK4W5L77.USD","MEDI","LU2505996509.AUD","LU2129689514.USD","LU2357305700.SGD","LU1003077747.HKD","LU0471298777.SGD","SG9999015978.USD","BK4550","LU0079474960.USD","WDNA","LU2471134879.HKD","LU0029864427.USD","LU0203201768.USD","LU1059921491.USD","LU0648001328.SGD","IE00BVYPNV92.GBP","BK4568","HRTS","LU0661504455.SGD","SG9999015341.SGD","LU1670710661.SGD","LU2324357040.USD","LU1989772923.USD","SG9999014542.SGD","IE00BJLML261.HKD","MHIP","LU0006306889.USD","LU1069344957.HKD","BK7508","IE00B2B36J28.USD","LU2133065610.SGD","IE00BDGV0183.EUR","LU1868836757.USD","IE00B3PB1722.GBP","IYH","BK4533","BK4599","LU0882574139.USD","LU2063271972.USD","LU2430703095.HKD","PPH","LU1929549753.HKD","LU2089284900.SGD","LU1868837300.USD","SG9999017495.SGD","LU2211815571.USD","LU0174119429.USD","LU1035773651.USD","LU1196500208.SGD","LU2361044865.SGD","LU1548497426.USD","ILDR","LU1674673691.USD","LU0225283273.USD","LU2756315664.SGD","IBB","LU2468319806.SGD","LU0689626769.HKD","SG9999014559.SGD","LU1032466523.USD","IE00BSNM7G36.USD","LU2168564149.EUR","LU1551013425.SGD","LU2417539215.USD","IE00B4R5TH58.HKD","LU2462157665.USD","GSK.UK","SG9999015952.SGD","IE00BLSP4452.SGD","LU0640476718.USD","SGXZ57979304.SGD","SG9999018865.SGD","LU0203202063.USD","LU0256863811.USD","LU0965509283.SGD","LU1868836591.USD","LU2430703178.SGD","LU2552382058.USD","LU1035775433.USD","LU1496350171.SGD","LU0345769631.USD","LU1066051498.USD","IE00BLSP4239.USD","LU0124676726.USD","IE00B7KXQ091.USD","LU2242646821.SGD","BK4139","IE000M9KFDE8.USD","LU2106854487.HKD","BK4583","LU0198837287.USD","PAWZ","LU1670627923.USD","LU0238689110.USD","LU2023250330.USD","SG9999003800.SGD","LU2237443382.USD","BK7501","LU2125154935.USD","LU1145028129.USD","LU1116320901.HKD","TMED","IE00B1BXHZ80.USD","LU0795875169.SGD","LU0225771236.USD","LU1244550577.SGD","BK4581","LU0225284248.USD","IE00BVYPNW00.USD","LU0210528500.USD","LLII","MEDX","TRUH","LLYX","LU2505996681.GBP","LU1551013342.USD","LU2602419157.SGD","IE00B3T34201.USD","LU2108987350.USD","LU1221951129.SGD","LU1291159041.SGD","LU0321505868.SGD","LU2491050154.USD","CSL.AU","LU0795875086.SGD","LU0345770308.USD","LU1868836914.USD","IE000SO60NU8.SGD","LU1121112475.USD","LU1720051017.SGD","LU2028103732.USD","LU2552382132.HKD","GILD","LU0321505439.SGD","LU0320765489.SGD","LU0266013472.USD","LU2491050071.SGD","SG9999014880.SGD","LU2023251221.USD","LU2237443549.SGD","LU0203345920.USD","LU1979441026.SGD","LU2087625088.SGD","LU0289739699.SGD","IE0000B7K699.USD","LU0133085943.USD","LU0980610538.SGD","LU0203347892.USD","SG9999014567.USD","LU1043141396.HKD","TBXU","PFE","LU0234570918.USD","SGXZ80539844.SGD","LU0943347566.SGD","LU1366192091.USD","LU1670628061.USD","LU1699723380.USD","LU0316494557.USD","LU1934455277.USD","LU0472753341.HKD","NVOX","LU0820561909.HKD","LU0210536198.USD","BK4585","IE0009355771.USD","LU0949170772.SGD","LU1571399168.USD","LU1917777945.USD","LU1883839398.USD","IE0004445239.USD","BK4566","LU1267930490.SGD","IE0005OL40V9.USD","IE00BJJMRY28.SGD","MRK","LU0823434740.USD","LU0385154629.USD","LU2168564495.EUR","AMGN","LU0106261372.USD","JNJ","LU1829250122.USD","LU2125909593.SGD","IE00BKPKM429.USD","LU0417517546.SGD","PJP","IE00BJJMRX11.SGD","IE000F7OJYX1.SGD","SG9999002224.SGD","LU0889565916.HKD","LU2471134952.CNY","SG9999013999.USD","LU1232071149.USD","BIIB","LU0310800379.SGD","LU0912757837.SGD","LU0265550359.USD","LU2125154778.USD","LU0545039389.USD","ABBV","LU0323591593.USD","LU0471298694.HKD","IE00BJJMRZ35.SGD","THNR","LU0786609619.USD","GLAM","LU2592432038.USD","BK4532","LU0345769128.USD","NVO","PBE","LU0395794307.EUR","LLY","LU1894683264.USD","LU2896262040.SGD","LU0320765992.SGD","IE00BFXG1179.USD","LU1674673428.USD","LU0158827948.USD","LU1127390331.HKD","IE0002141913.USD","LU0109391861.USD","LU0477156953.USD","BK4007","LU0726765562.USD","IE000BZT7R73.USD","LU1057294990.SGD","LU0820561818.USD","LU1074936037.SGD","AZNH","IE00BN29S564.USD","ELIL","IE00B19Z9P08.USD","LU2456880835.USD","OZEM","LU2430703251.USD","LU2360032135.SGD","FTXH","LU0672654240.SGD","GB00BDT5M118.USD","NVOH","BK4534","IE00B19Z9Z06.USD","IBBQ","LU0432979614.USD","LU1064131342.USD","LU0353189680.USD","LU1935042991.SGD","LU2237443895.HKD","LU0708994859.HKD","LU1496350502.SGD","IE00BN8TJ469.HKD","LU0320765059.SGD","LU0820562030.AUD","LU1778281490.HKD","AZN","LU2023250504.SGD","LU1267930573.SGD","JDOC","LU0354030511.USD","BK4592","LU0211328371.USD","LU0738911758.USD","IE00BKDWB100.SGD","LU0426412945.USD","LU2237443622.USD","LU2087621335.USD","IE00B7SZLL34.SGD","IE00BFSS7M15.SGD","LU1989772840.SGD","XLV","SG9999014914.USD","LU1093756168.USD","LU0162691827.USD","SG9999002232.USD","LU0094547139.USD","LU1894683348.USD","IE00B42XCP33.USD","IE00BGHQF631.EUR","SG9999011175.SGD","LU0683600562.USD","IXJ","LU1934455194.USD","LU1061106388.HKD","LU0057025933.USD","BBH","SG9999015358.SGD","LU2089984988.USD","LU2361045086.USD","LU1670711040.USD","IE00BFSS8Q28.SGD","LU2023250843.SGD","SGXZ51526630.SGD","LU1941712348.USD","LU1804176565.USD","LU0267386448.USD","BK4578","LU0306807586.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU1244550494.USD","LU1623119135.USD","LU1066053197.SGD","LU0072461881.USD","SG9999014575.USD","LU0128525929.USD","CANC","LU0889566641.SGD","LU1032955483.USD","SG9999014906.USD","ELIS","BK4516","LU0306806265.USD","LU1712237335.SGD","BMED","SG9999015945.SGD","LU1670711123.USD","IE00BBT3K403.USD","LU2112291526.USD","LLYZ","LU0310799852.SGD","BMY","LU0545562505.USD","FHLC","LU1720051108.HKD","IE00BK4W5M84.HKD","LU0256863902.USD","IE0034235303.USD","LU0345770993.USD","LU0882574055.USD","BK4588","GSKH","LU1267930730.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157924766","title":"CSL有限公司：歐盟委員會決定撤銷Tavneos在歐盟及歐洲經濟區國家的上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1157924766","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157924766?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 14:02","pubTimestamp":1785996168,"startTime":"0","endTime":"0","summary":"CSL有限公司（CSL LIMITED）发布公告称，欧盟委员会已正式通过一项决定，撤销其药物Tavneos在欧盟及欧洲经济区国家境内的上市许可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7511","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137659350","title":"異動解讀 | CSL Limited盤中大漲5%，宣佈啓動下一代免疫球蛋白臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1137659350","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137659350?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 08:14","pubTimestamp":1785284068,"startTime":"0","endTime":"0","summary":"CSL Limited（CSL.AU）今日盘中股价大涨5%，引发市场关注。消息面上，CSL在盘前宣布，将启动一项临床试验工作，旨在验证其采用下一代Horizon 2工艺生产的免疫球蛋白的有效性和安全性。这一举措标志着公司在该关键领域的技术创新迈入临床验证阶段，有望进一步提升产品竞争力和市场前景，从而提振了投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150998107","title":"CSL有限公司將開展臨床試驗，驗證下一代Horizon 2工藝生產的免疫球蛋白有效性與安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1150998107","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150998107?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 07:22","pubTimestamp":1785280928,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布，将启动一项临床试验工作，旨在确认其采用下一代Horizon 2工艺生产的免疫球蛋白的有效性和安全性。这一举措标志着公司在该领域的技术创新迈入关键验证阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103960538","title":"安登布里（Andembry）展現良好安全性；多數患者在12個月治療期內未出現發作","url":"https://stock-news.laohu8.com/highlight/detail?id=1103960538","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103960538?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 21:01","pubTimestamp":1785157276,"startTime":"0","endTime":"0","summary":"CSL公司旗下的安登布里（Andembry）在安全性方面表现令人满意。一项为期12个月的治疗数据显示，大多数患者在整个治疗周期内始终保持无发作状态。这一结果凸显了该药物的安全性与疗效潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","CSL.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175437809","title":"CSL公布Andembry®治療兒童遺傳性血管性水腫IIIb期積極結果，支持擴大兒科適應症申報","url":"https://stock-news.laohu8.com/highlight/detail?id=1175437809","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175437809?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 21:01","pubTimestamp":1785157269,"startTime":"0","endTime":"0","summary":"CSL LIMITED（CSL.AU）近日宣布，其针对Andembry®（Garadacimab-Gxii）在儿童遗传性血管性水肿（HAE）患者中开展的IIIb期临床研究，取得了积极的顶线结果。这些数据将有力支持该公司计划中的扩大儿科适应症申报工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","CSL.AU","BK7067","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181965912","title":"歐盟就賽諾菲針對競爭對手流感疫苗可能存在的反競爭行為徵集反饋意見","url":"https://stock-news.laohu8.com/highlight/detail?id=1181965912","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181965912?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 17:46","pubTimestamp":1783503996,"startTime":"0","endTime":"0","summary":"欧盟委员会正就赛诺菲公司提出的承诺方案公开征求意见，这些承诺旨在解决其可能存在的反竞争行为。该行为涉及针对特定脆弱患者群体的竞争对手流感疫苗。此举源于欧盟对赛诺菲可能滥用市场支配地位的调查。赛诺菲已提交一系列承诺，试图消除欧盟的竞争担忧。欧盟委员会现邀请市场参与者、竞争对手及公众在指定期限内，对这些承诺措施能否有效恢复相关市场的公平竞争环境提出反馈。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133109014","title":"賽諾菲回應歐盟調查：堅信自身行為始終完全符合所有適用法律法規","url":"https://stock-news.laohu8.com/highlight/detail?id=1133109014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133109014?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 18:21","pubTimestamp":1782469273,"startTime":"0","endTime":"0","summary":"针对欧盟的调查，赛诺菲发言人表示，公司坚信其过去及当前的所有行为均完全符合所有适用的法律与法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","CSL.AU","BK7511","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177213732","title":"賽諾菲就歐盟調查發表聲明：在整個過程中與歐盟委員會保持全面合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1177213732","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177213732?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 18:20","pubTimestamp":1782469218,"startTime":"0","endTime":"0","summary":"赛诺菲发言人针对欧盟调查一事表示，公司正与欧盟委员会保持全面合作，并将在整个过程中持续提供所需信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7508","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646794508","title":"分析-2025年，隨着高價基因療法上市數量減少，美國新藥價格出現下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2646794508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646794508?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 18:01","pubTimestamp":1782381707,"startTime":"0","endTime":"0","summary":"分析-2025年，随着高价基因疗法上市数量减少，美国新药价格出现下降2025年获FDA批准的药品年均标价中位数为216,000美元2025年，FDA批准了51种新药，其中包括5种细胞和基因疗法2025年获批药物中，小分子药物占比超过67%，高于2024年的62%Deena Beasley路透6月25日-一项最新分析显示，2025年美国监管机构批准的处方药上市价格虽较上年有所下降，但受罕见病高价药物影响，中位数仍高达216,000美元。基因疗法通常只需给药一次，其价格可能高达数百万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","JAZZ","IONS","LU0109394709.USD","CSL.AU","BK4588","BK4139","IE00BN0W2V16.EUR","BK4585","BK7007","LU0882574055.USD","BK7511","LU0154245673.USD","LU0889565916.HKD","LU0320765992.SGD","BK7501","BK7508","ABEO","LU0154245756.USD","IE00BN0W2W23.USD","NTI.AU","BK7067","BK4007","LU0823416689.USD","LU0114720955.EUR","BK4539","LENZ","BK4533","IE00BN0W2T93.GBP","BK4548","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646810778","title":"得克薩斯州訓練中心爆發疫情後，美軍要求部分人員接種流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2646810778","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646810778?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 02:27","pubTimestamp":1782325631,"startTime":"0","endTime":"0","summary":"得克萨斯州训练中心爆发疫情后，美军要求部分人员接种流感疫苗路透6月24日-美国军方已恢复要求部分军人接种流感疫苗，这与国防部长皮特·赫格塞斯两个月前发布的、将接种定为自愿的指导方针形成例外。赫格塞斯今年4月曾表示，根据五角大楼的新疫苗政策，所有美军人员每年接种流感疫苗将 成为自愿行为。此前，接种流感疫苗曾是强制性的，并被视为部队战备的关键环节。世界卫生组织建议6个月及以上人群接种流感疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nL4T42W1N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0171276677.USD","LU0526926950.USD","LU0211326755.USD","LU0997586515.USD","LU1989772840.SGD","LU1291159041.SGD","LU1119994496.HKD","LU1064927863.SGD","LU2091194634.USD","LU1267930813.SGD","LU2539964713.USD","LU0266013472.USD","LU0708994859.HKD","IE00BKPKM643.USD","LU1019632923.USD","03165","BK5011","IE00BJJMRZ35.SGD","LU0211328371.USD","LU0640478417.SGD","LU1019634622.SGD","IE00B3T34201.USD","LU1323610961.USD","LU0390134368.USD","LU1051770623.HKD","LU0052756011.USD","LU2237443549.SGD","LU0289739699.SGD","LU2293690249.USD","LU2433249047.HKD","LU1481600234.SGD","LU2133065610.SGD","LU0792757196.USD","LU0964806797.USD","AZN.UK","LU0310800379.SGD","LU1153585028.USD","LU2324357040.USD","LU0047473722.EUR","CSL.AU","LU1046234339.USD","LU0545039389.USD","LU2279689827.SGD","LU1301847155.USD","LU0310799852.SGD","LU0345777147.USD","LU0949170772.SGD","LU1104425308.USD","LU0128525689.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}